|
|
|
|
||
CALA newsCalithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 for Treatment of Patients with Renal Cell Carcinoma |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1520 | Re: CALA news | hachibahn | 1 | 6/7/2017 11:01:00 AM |